| pubmed-article:7803769 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7803769 | lifeskim:mentions | umls-concept:C0074830 | lld:lifeskim |
| pubmed-article:7803769 | lifeskim:mentions | umls-concept:C0339143 | lld:lifeskim |
| pubmed-article:7803769 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:7803769 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:7803769 | pubmed:dateCreated | 1995-1-27 | lld:pubmed |
| pubmed-article:7803769 | pubmed:abstractText | Somatostatin receptor scintigraphy with 111In-labeled octreotide proves to be a very sensitive diagnostic tool for evaluation of inflammative activity in endocrine ophthalmopathy (EO). The results of somatostatin receptor scintigraphy (SRS) in 40 patients with EO show a high orbital accumulation of 111In-octreotide in clinically active EO (4 h-median/orbit-brain-ratio: 12.6; controls 4 h-median: 5.8) Patients with clinically inactive EO (4 h-median: 7.1) show a similar orbital accumulation of radioactivity compared to controls. 5 patients with active orbital myositis also revealed an even higher orbital accumulation of radioactivity (4 h-median: 42.3). The diagnostic value of SRS lies in its ability to act as a measure of inflammation and can be useful as an activity parameter when planning therapeutic procedure as well as for EO follow-up. The results in patients with orbital myositis nevertheless do not permit a differential diagnosis with this method. The therapeutic value of 111In-octreotide in Graves' disease has yet to be established. | lld:pubmed |
| pubmed-article:7803769 | pubmed:language | ger | lld:pubmed |
| pubmed-article:7803769 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7803769 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7803769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7803769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7803769 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7803769 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7803769 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:7803769 | pubmed:issn | 1438-9029 | lld:pubmed |
| pubmed-article:7803769 | pubmed:author | pubmed-author:BeyerJJ | lld:pubmed |
| pubmed-article:7803769 | pubmed:author | pubmed-author:BockischAA | lld:pubmed |
| pubmed-article:7803769 | pubmed:author | pubmed-author:HahnKK | lld:pubmed |
| pubmed-article:7803769 | pubmed:author | pubmed-author:DiazMM | lld:pubmed |
| pubmed-article:7803769 | pubmed:author | pubmed-author:KahalyGG | lld:pubmed |
| pubmed-article:7803769 | pubmed:author | pubmed-author:MühlbachAA | lld:pubmed |
| pubmed-article:7803769 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7803769 | pubmed:volume | 161 | lld:pubmed |
| pubmed-article:7803769 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7803769 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7803769 | pubmed:pagination | 484-8 | lld:pubmed |
| pubmed-article:7803769 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:meshHeading | pubmed-meshheading:7803769-... | lld:pubmed |
| pubmed-article:7803769 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7803769 | pubmed:articleTitle | [Somatostatin receptor scintigraphy in endocrine orbitopathy]. | lld:pubmed |
| pubmed-article:7803769 | pubmed:affiliation | Klinik und Poliklinik für Nuklearmedizin, Johannes-Gutenberg-Universität Mainz. | lld:pubmed |
| pubmed-article:7803769 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7803769 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7803769 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7803769 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:7803769 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
